Finasteride Tablet, Film Coated
Product Images NDC 68645-541

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 68645-541). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Legacy Pharmaceutical Packaging, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure.jpg (Finasteride Bottle Camber 1)

Chemical structure of Finasteride, showing its tetracyclic ring system with specific functional groups including a ketone and amide.*

FDA Label Image

Figure1.jpg (Finasteride Bottle Camber 2)

A line graph comparing mean change from baseline in a variable over four years between Finasteride 5 mg and placebo groups. The x-axis represents time points from baseline to year 4, and the y-axis shows mean change with standard error. Finasteride group shows greater reduction than placebo over time, with sample sizes noted for each year.*

FDA Label Image

Figure2.jpg (Finasteride Bottle Camber 3)

A line graph titled 'Figure 2 Percent of Patients Having Surgery for BPH, Including TURP' comparing the percent of patients over a 48-month observation period between a Finasteride group and a Placebo group. The graph shows cumulative data with the Finasteride group consistently having a lower percentage of patients undergoing surgery compared to the Placebo group. Below the graph, event counts and number at risk per year are tabulated for both groups at multiple time points.*

FDA Label Image

Figure3.jpg (Finasteride Bottle Camber 4)

A line graph showing mean percent change from baseline over four years for two groups: placebo and finasteride. The vertical axis represents mean percent change, with values from -20 to 20. The horizontal axis shows time points at baseline and years 1 through 4. Data point counts for each group are listed below the graph for each time point.*

FDA Label Image

Figure4.jpg (Finasteride Bottle Camber 5)

A line graph depicting the percentage of participants with an event over 5.5 years from randomization. It compares four groups: Placebo, Finasteride, Doxazosin, and Combination, with Placebo showing the highest percentage and Combination the lowest across time.*

FDA Label Image

Address.jpg (Finasteride Bottle Camber 6)

FDA Label Image

Address3.jpg (Finasteride Bottle Camber 7)

FDA Label Image

Finasteride Tablets, Usp 5 mg (Finasteride Bottle Camber 8)

Finasteride 5 mg film-coated tablets label showing a package of 30 tablets. The label includes the name Finasteride Tablets, USP, strength 5 mg, and an imprint of the tablets marked with H and 37. It states the product is for oral use and prescription only (Rx Only). Packaged by Legacy Pharmaceutical Packaging LLC, Earth City, MO, and distributed by Walmart, Bentonville, AR. Storage instructions and a warning for use by women or children are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.